Nureca
Nureca Share Price Chart
Nureca last traded at ₹330.00 (2026-10-13). Over the past month the stock moved -3.1%, three months the stock moved +20.3%, year the stock moved +30.7%. Its closing range over 52 weeks is ₹216.25 – ₹371.90, with the latest close 11.3% below the high.
Closing prices up to 2026-10-13.
About Nureca
Incorporated in 2016, Nureca Ltd is in the business of Home Healthcare and Wellness Products.[1]
Business Overview:[1][2] NL is a digitally first, consumer healthcare company with presence in categories such as home diagnostics, wellness devices, and personal fitness equipment under brands like Dr Trust and Dr Physio. The company has 277+ Active SKUs, and 7 New Products were launched during Q1FY26
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Nureca reported sales of ₹40.34 crore (+18.0%) and net profit of ₹3.07 crore (+279.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 40.34 | 3.42 | 8.48 | 3.07 | 3.22 |
| Mar 2026 | 35.41 | -5.78 | -16.32 | -6.09 | -6.38 |
| Dec 2025 | 39.64 | 3.25 | 8.20 | 3.73 | 3.91 |
| Sep 2025 | 37.74 | 3.27 | 8.66 | 3.63 | 3.63 |
| Jun 2025 | 34.18 | -0.56 | -1.64 | 0.81 | 0.81 |
| Mar 2025 | 31.74 | 1.20 | 3.78 | 2.47 | 2.47 |
| Dec 2024 | 26.46 | -4.01 | -15.15 | -2.80 | -2.80 |
| Sep 2024 | 31.19 | -2.35 | -7.53 | -0.48 | -0.48 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -0.5% | +18.3% | +87.0% | +68.6% | +21.0% | +49.8% | +11.6% | +18.0% |
| Operating profit growth | -270.3% | – | – | – | – | – | -581.7% | – |
| Net profit growth | -116.6% | -1747.1% | – | -51.2% | – | – | -346.6% | +279.0% |
| EPS growth | -116.6% | -1747.1% | – | -51.2% | – | – | -358.3% | +297.5% |
| OPM % | -7.5% | -15.2% | 3.8% | -1.6% | 8.7% | 8.2% | -16.3% | 8.5% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Nureca reported sales of ₹147.00 crore (+33.6%) and net profit of ₹2.00 crore (+100.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 147.00 | 0.00 | 0.00 | 2.00 | 2.18 |
| Mar 2025 | 110.00 | -8.00 | -7.00 | 1.00 | 0.85 |
| Mar 2024 | 92.00 | -10.00 | -11.00 | -2.00 | -1.79 |
| Mar 2023 | 111.00 | -15.00 | -13.00 | -8.00 | -8.25 |
| Mar 2022 | 256.00 | 56.00 | 22.00 | 45.00 | 44.96 |
| Mar 2021 | 213.00 | 62.00 | 29.00 | 46.00 | 46.37 |
| Mar 2020 | 99.00 | 10.00 | 10.00 | 6.00 | 6,400.00 |
| Mar 2019 | 62.00 | 9.00 | 15.00 | 6.00 | 6,230.00 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales growth | +59.7% | +115.2% | +20.2% | -56.6% | -17.1% | +19.6% | +33.6% |
| Operating profit growth | +11.1% | +520.0% | -9.7% | -126.8% | – | – | – |
| Net profit growth | +0.0% | +666.7% | -2.2% | -117.8% | – | – | +100.0% |
| EPS growth | +2.7% | -99.3% | -3.0% | -118.3% | – | – | +156.5% |
| OPM % | 10.0% | 29.0% | 22.0% | -13.0% | -11.0% | -7.0% | 0.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Nureca.
Get Free AI Stock Analysis FREE →Latest News
-
Nureca Standalone June 2026 Net Sales at Rs 40.40 crore, up 17.69% Y-o-Y - Moneycontrol.com
-
Nureca consolidated net profit rises 279.01% in the June 2026 quarter - Business Standard
-
Nureca consolidated net profit rises 279.01% in the June 2026 quarter - Business Standard
Frequently Asked Questions
What is the share price of Nureca today?
Nureca shares were last quoted at ₹330.00 (-0.5% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Nureca?
Nureca has a price-to-earnings (P/E) ratio of 80.88 and a price-to-book (P/B) ratio of 1.90. The industry P/E is 45.63.
What is the 52-week high and low of Nureca?
The 52-week high of Nureca is ₹358.00 and the 52-week low is ₹200.10.
What is the market cap of Nureca?
The market capitalisation of Nureca is about ₹351.01 crore.
How did Nureca perform in its latest quarterly results?
In the latest quarter (Jun 2026), Nureca reported sales of ₹40.34 crore (+18.0%) and net profit of ₹3.07 crore (+279.0%), compared with the same quarter last year.
Is Nureca a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Nureca has a 3-year ROE of -1.00%, 3-year profit growth of 30.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Nureca?
Promoters hold about 68.09% of Nureca.
Which sector does Nureca belong to?
Nureca belongs to the Medical Equipment/Supplies/Accessories sector.
Other Medical Equipment/Supplies/Accessories stocks
- Poly Medicure
- Indegene
- Molbio Diagnostics
- Aarti Pharmalabs
- Q-Line Biotech
- Hemant Surgical Industries
- Prevest Denpro
- QMS Medical Allied Services
All Medical Equipment/Supplies/Accessories stocks · Browse all stocks A–Z